HAX

Founded 2011
Founders Cyril Ebersweiler Sean O'Sullivan

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 438
Average round size
info
The average size of a deal this fund participated in
$308K
Portfolio companies 254
Rounds per year 43.80
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.45
Exits 5
Key employees 2
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Hardware
  • Health Care
  • Robotics
  • Internet of Things
  • Software
Summary

HAX is the famous Corporate Investor, which was founded in 2011. The main department of described Corporate Investor is located in the Shenzhen. The company was established in Asia in China.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the HAX, startups are often financed by Velocity, Urban Us, Enterprise Ireland. The meaningful sponsors for the fund in investment in the same round are Urban Us, Qualgro VC, SOSV. In the next rounds fund is usually obtained by Root Ventures, Urban Us, Qualgro VC.

Opposing the other organizations, this HAX works on 28 percentage points less the average amount of lead investments. When the investment is from HAX the average startup value is 1-5 millions dollars. The common things for fund are deals in the range of 100 thousands - 1 million dollars. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. The higher amount of exits for fund were in 2018. The real fund results show that this Corporate Investor is 19 percentage points less often commits exit comparing to other companies. The fund is constantly included in 25-48 investment rounds annually.

For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline Roadie, SEPPURE, Preemadonna Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Among the most popular fund investment industries, there are Wearables, Manufacturing.

The current fund was established by Cyril Ebersweiler.

Read more

Notable deals

CompanyIndustryRoundRound SizeDateInvestorsLocation

Flow Neuroscience

Health Care
Medical Device
1
$9M10 Aug 2021 Sweden, Malmo

Allozymes

B2B
Biotechnology
1
$5M06 Jul 2021

Criam

Biotechnology
Health Care
Life Science
Medical
Medical Device
Pharmaceutical
1
23 Jun 2021 Portugal, Braga

AntePlastics

Recycling
Renewable Energy
Waste Management
1
10 Jun 2021 Singapore, Singapore

neurode

Health Care
Medical
Medical Device
Therapeutics
1
02 Jun 2021 Australia, Sydney

ACiiST

Communications Infrastructure
Internet of Things
Smart Cities
1
20 May 2021 Israel, " Israel"}

Simbe Robotics

Retail Technology
Robotics
Sales Automation
n/a
14 May 2021 United States, San Francisco

RayIoT

Consumer Electronics
Electronics
Health Care
1
05 May 2021 United States, Falls Church

Backbar Solutions

Food and Beverage
Hospitality
n/a
30 Apr 2021 United States, Atlanta
News
RxAll grabs $3.15M to scale its drug checking and counterfeiting tech across Africa
– RxAll, a startup using deep technology to provide quality medication to patients, raised $3.15m in funding. – Launch Africa led the round with participation from SOSV’s HAX and Keisuke Honda. – The company plans to scale across existing markets and improve its technology. Read more
Allozymes looks to upend chemical manufacturing with rapid enzyme engineering and $5M seed
– Allozymes is a company that aims to change the way enzymes are discovered. – The company raised $5m in seed funding. – The round was led by Xora Innovation, with participation from HAX, Entrepreneur First and TI Platform Management. – The company plans to incorporate in the U.S. following interest from American venture firms. Read more

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent HAX?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: